Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
330
datasets available to search
ShareScore release 0.7.1
Dataset results
330 results for “non-alcoholic fatty liver disease”
The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes
ClinicalTrials.gov study NCT01855386. IPD Sharing: NO. Countries: 1. Publications: 0.
Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01680003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ketogenic Diet in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03784716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease
ClinicalTrials.gov study NCT01638832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Human hepatocyte PNPLA3 148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice
GEO Series GSE166693. Mus musculus. 25 samples. Type: Expression profiling by high throughput sequencing.
Integrated Gut/Liver-on-a-Chip platform as in vitro human model of non-alcoholic fatty liver disease
GEO Series GSE206417. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Hepatic Transcriptome Profiling of A Multiethnic Cohort of Pediatric Non-Alcoholic Fatty Liver Disease Patients Reveals Novel Genes and Pathways Associated With Disease Stages
GEO Series GSE185051. Homo sapiens. 57 samples. Type: Expression profiling by high throughput sequencing.
Data from: Non-invasive stratification of non-alcoholic fatty liver disease by whole-transcriptome cell-free mRNA characterization
Open the record for dataset details and reuse information.
Data from: Nut intake and non-alcoholic fatty liver disease risk
Open the record for dataset details and reuse information.
Placebo-controlled, randomized clinical trial with repeated liver biopsies: Long-term resveratrol treatment has no clear therapeutic benefit in non-alcoholic fatty liver disease
GEO Series GSE68421. Homo sapiens. 32 samples. Type: Expression profiling by array.
Single Nuclei RNA-Seq to map progression of non-alcoholic fatty liver disease (NAFLD) in patients II
GEO Series GSE202379. Homo sapiens. 59 samples. Type: Expression profiling by high throughput sequencing.
Macrophage-derived thrombospondin1 promotes obesity-associated non-alcoholic fatty liver disease
GEO Series GSE155973. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Microbiota modulation by dietary oat beta-glucan prevents Non-alcoholic fatty liver disease progression
GEO Series GSE246738. Mus musculus. 19 samples. Type: Expression profiling by high throughput sequencing.
Analysis of N6-methyladenosine Methylation Modification in Fructose-induced Non-alcoholic Fatty Liver Disease [MeRIP-Seq]
GEO Series GSE184814. Mus musculus. 16 samples. Type: Methylation profiling by high throughput sequencing.
Industrial trans fatty acids stimulate SREBP2-mediated cholesterogenesis and promote non-alcoholic fatty liver disease
GEO Series GSE136354. Mus musculus. 32 samples. Type: Expression profiling by array.
Analysis of N6-methyladenosine Methylation Modification in Fructose-induced Non-alcoholic Fatty Liver Disease [RNA-Seq]
GEO Series GSE184813. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
Spatial transcriptomic analysis reveals increased adipogenesis and non-alcoholic fatty liver disease pathway in pig-to-NHP islet transplantation recipient liver during early post-transplantation perio
GEO Series GSE261581. Macaca mulatta. 18 samples. Type: Other.
Ablation of dual specificity phosphatase 6 protects against non-alcoholic fatty liver disease via CYP4A and MAPK
GEO Series GSE216881. Mus musculus. 4 samples. Type: Expression profiling by high throughput sequencing.
Animal study to validate effects of ACOT1 in Non-alcoholic Fatty Liver Disease (NAFLD)
GEO Series GSE174797. Mus musculus. 9 samples. Type: Expression profiling by array.
Role of caveolin-1 in hepatocellular carcinoma arising from non-alcoholic fatty liver disease
GEO Series GSE99131. Homo sapiens. 6 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.